131 related articles for article (PubMed ID: 24362721)
1. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Fagotti A; Fanfani F; Parazzini F; Schiavina R; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jan; 24(1):156-64. PubMed ID: 24362721
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
3. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
5. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
Zhang Z; Zang R; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
[TBL] [Abstract][Full Text] [Related]
6. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
8. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
9. Influence of tumor size on outcomes following pelvic exenteration.
Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
[TBL] [Abstract][Full Text] [Related]
10. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
[TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
Dottino PR; Segna RA; Jennings TS; Mandeli JP; Konsker K; Cohen CJ
Mt Sinai J Med; 1995 Nov; 62(6):431-5. PubMed ID: 8692157
[TBL] [Abstract][Full Text] [Related]
12. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Rios-Doria E; Filippova OT; Straubhar AM; Chi A; Awowole I; Sandhu J; Broach V; Mueller JJ; Gardner GJ; Jewell EL; Zivanovic O; Leitao MM; Long Roche K; Abu-Rustum NR; Sonoda Y
Gynecol Oncol; 2022 Nov; 167(2):277-282. PubMed ID: 36064678
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
16. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
[TBL] [Abstract][Full Text] [Related]
17. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
18. Pelvic exenteration for the treatment of gynecological malignancies.
Numa F; Ogata H; Suminami Y; Tsunaga N; Nakamura Y; Tamura H; Takasugi N; Kato H; Tangoku A; Uchiyama T; Oka M; Suzuki T; Yamamoto M; Naito K
Arch Gynecol Obstet; 1997; 259(3):133-8. PubMed ID: 9187465
[TBL] [Abstract][Full Text] [Related]
19. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]